SCHEMBL21027832

SCHEMBL21027832

Cc1cc(N)nc(C)c1CNCc1nnc(Cc2cc(C(C)(C)O)c3ncc(Cl)cc3c2)o1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 20/20 0.44
MAP4K1 Q92918 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19780133 0.86 KLKB1 (0.61) KLKB1MAP4K1
SCHEMBL24117416 0.86 KLKB1 (0.42) KLKB1MAP4K1
SCHEMBL22446432 0.84 KLKB1 (0.47) KLKB1MAP4K1
SCHEMBL24117422 0.81 KLKB1 (0.57) KLKB1MAP4K1
SCHEMBL20531694 0.76 KLKB1 (0.49) KLKB1MAP4K1
SCHEMBL18416794 0.75 KLKB1 (0.63) KLKB1MAP4K1
SCHEMBL21177287 0.74 KLKB1 (0.47) KLKB1MAP4K1
SCHEMBL19780121 0.74 KLKB1 (0.63) KLKB1
SCHEMBL20531619 0.74 KLKB1 (0.42) KLKB1
SCHEMBL21027806 0.73 KLKB1 (0.52) KLKB1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301284-B2 Therapeutic inhibitory compounds LIFESCI PHARMACEUTICALS, INC. (BB) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301284-B2 Therapeutic inhibitory compounds KLKB1, SERPINB1, SERPINE1 KLKB1 1/4885MAP4K1 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.